|
MYEF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.538300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.584400E-02 |
| Normal-vs-Stage2 |
2.372000E-01 |
| Normal-vs-Stage3 |
8.822200E-01 |
| Normal-vs-Stage4 |
6.495000E-01 |
| Stage1-vs-Stage2 |
7.460200E-01 |
| Stage1-vs-Stage3 |
7.730200E-02 |
| Stage1-vs-Stage4 |
1.322090E-02 |
| Stage2-vs-Stage3 |
2.745800E-01 |
| Stage2-vs-Stage4 |
1.727000E-01 |
| Stage3-vs-Stage4 |
5.569800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.599200E-03 |
| Normal-vs-AfricanAmerican |
1.119800E-01 |
| Normal-vs-Asian |
4.345800E-01 |
| Caucasian-vs-AfricanAmerican |
6.043200E-01 |
| Caucasian-vs-Asian |
3.676100E-02 |
| AfricanAmerican-vs-Asian |
8.898200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.856490E-02 |
| Normal-vs-Female |
9.603900E-03 |
| Male-vs-Female |
2.063800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.273370E-01 |
| Normal-vs-Extreme_Weight |
1.174230E-01 |
| Normal-vs-Obese |
1.943620E-02 |
| Normal-vs-Extreme_Obese |
4.834000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.964400E-01 |
| Normal_Weight-vs-Obese |
4.881600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.535800E-01 |
| Extreme_Weight-vs-Obese |
4.666400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.842000E-01 |
| Obese-vs-Extreme_Obese |
5.833600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.043980E-01 |
| Normal-vs-Age(41-60Yrs) |
1.255380E-03 |
| Normal-vs-Age(61-80Yrs) |
6.882000E-02 |
| Normal-vs-Age(81-100Yrs) |
9.167400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.918200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.985200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.136200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.092790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.718390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.205400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.82449999999168E-05 |
| Normal-VS-Type2 PRCC |
1.418560E-01 |
| Normal-VS-KIRP CIMP |
5.688200E-01 |
| Normal-VS-Unclassified PRCC |
1.606230E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.80979997654873E-09 |
| Type1 PRCC-VS-KIRP CIMP |
4.492200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.729700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.693760E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.608170E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.312000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.559000E-01 |
| Normal-vs-N1 |
2.907800E-01 |
| Normal-vs-N2 |
2.916600E-01 |
| N0-vs-N1 |
3.276600E-01 |
| N0-vs-N2 |
4.773800E-01 |
| N1-vs-N2 |
2.643800E-01 |
|
|
